Editor(s):

(1) Dr. Mohamed Fawzy Ramadan Hassanien, Professor, Zagazig University, Egypt.

Reviewers:

(1) Pedro de Souza Lucarelli Antunes, Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil.

(2) Abdussemee Idowu Abdurrazzaaq, Federal Medical Centre Abeokuta, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Pedro de Souza Lucarelli Antunes, Brazil) | File 1 | File 2

Stage 2 | Peer review report_2 (Abdussemee Idowu Abdurrazzaaq, Nigeria) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1)Karin Kato, Kyoto University Hospital, Japan.

(2) Divij Khetan, Khetan Hospital, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Karin Kato, Japan) | File 1 | NA

Stage 2 | Peer review report_2 (Divij Khetan, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

(2) Dr. Giulio Tarro, Professor & President, Foundation T. & L. de Beaumont Bonelli for Cancer Research, Italy.

Reviewers:

(1) Serdar Altınay, University of Health Sciences, Turkey.

(2) Nikita Agrawal, College of Dental Sciences and Hospital Indore, India.

Additional Reviewers:

(1) Pedro Henrique Cossu Vallejo, Barretos Cancer Hospital, Brazil.

(2) Mithra N Hegde, A B Shetty Memorial Institute of Dental Sciences, NITTE (Deemed to be University), India.

(3) Sávio Morato De Lacerda Gontijo, UNA – Bom Despacho, Brazil.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Serdar Altınay, Turkey) | File 1 | NA

Stage 2 | Peer review report_2 (Nikita Agrawal, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan.

Reviewers:

(1) P Chitra,Sathyabama Institute of Science and Technology, India.

(2) Mahmoud Abdel-Aziz Ibrahim, National Research Center, Giza, Egypt.

Additional Reviewers:

(1) Falak Zeb, National University of Medical Sciences, Pakistan.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (P Chitra, India) | File 1 | NA

Stage 2 | Peer review report_2 (Mahmoud Abdel-Aziz Ibrahim, Egypt) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan.

Reviewers:

(1) M.Palaniyandi, ICMR-Vector Control Research Centre, India.

(2) Vindhiya K, Sree Balaji Medical College and Hospital, India.

Additional Reviewers:

(1) S.Sivaprasad, MNR College of Pharmacy, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (M. Palaniyandi, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Vindhiya K, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, College of Pharmacy, Al-Quds University, Palestine.

Reviewers:

(1) Kshirod Kumar Ratha, Central Ayurveda Research Institute for Hepatobiliary Disorders, India.

(2) Muzammil Mumtaz, The University of Toledo, USA.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 5.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Kshirod Kumar Ratha, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Muzammil Mumtaz, USA) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Mohamed Fawzy Ramadan Hassanien, Professor, Zagazig University, Egypt.

Reviewers:

(1) Josiane Moreira da Costa, René Rachou Institute – Fiocruz Minas, Brazil.

(2) Chalkiadakis Vasileios, General Children’s Hospital “AGIA SOFIA”, Greece.

(3) Sujatha Nagari, NRI Institute of Medical Sciences, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 5.83/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Josiane Moreira da Costa, Brazil) | File 1 | File 2

Stage 2 | Peer review report_2 (Chalkiadakis Vasileios, Greece) | File 1 | NA

Stage 2 | Peer review report_3 (Sujatha Nagari, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Jongwha Chang, University of Texas, College of Pharmacy, USA.

(2) Dr. Barkat Ali Khan, Gomal University, Pakistan.

Reviewers:

(1) Marcelo Dalbosco-Salas, Universidad de las Américas, Chile.

(2) Afolabi T. Oluwasegun, University of Medical Science Nigeria, Nigeria.

(3) Ming Yang, The University of Hong Kong, China.

Additional Reviewers:

(1) Michael Zhipeng Yan, University of Hong Kong, China.

(2) Sherifa Mostafa M. Sabra, Taif U., KSA.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.33/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Marcelo Dalbosco-Salas, Chile) | File 1 | NA

Stage 2 | Peer review report_2 (Afolabi T. Oluwasegun, Nigeria) | File 1 | NA

Stage 2 | Peer review report_3 (Ming Yang, China) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.

Reviewers:

(1) Sharath. A, Rajiv Gandhi University of Health Sciences, India.

(2) Tahir Jameel, King Abdulaziz University Jeddah, Saudi Arabia.

Additional Reviewers:

(1) Georg Voelcker, Goethe University Frankfurt, Germany.

(2) Michael Chukwudi Ezeani, Nnamdi Azikiwe University Nnewi Campus, Nigeria.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Sharath. A, India) | File 1 | NA

Stage 2 | Peer review report_2 (Tahir Jameel, Saudi Arabia) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giulio Tarro, Professor & President, Foundation T. & L. de Beaumont Bonelli for cancer Research, Italy.

Reviewers:

(1) D. Srihari S. Kumar Raju, Maharajah’s Institute of Medical Sciences, India.

(2) Bipin Chaurasia, Bhawani Hospital and Research Centre, Nepal.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (D. Srihari S. Kumar Raju, India) | File 1 | NA

Stage 2 | Peer review report_2 (Bipin Chaurasia, Nepal) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA